Malignant Brain and Spinal Tumors Originating from Bone or Cartilage

Overview

Journal Adv Exp Med Biol

Specialties Biology
General Medicine

Date 2023 Jul 15

PMID 37452950

Authors

Zachary C Gersey

Georgios A Zenonos

Paul A Gardner

Affiliations

Soon will be listed here.

Abstract

Malignant bone tumors affecting the brain and spine are a rare and exceedingly difficult-to-treat group of diseases. Most commonly consisting of chordoma and chondrosarcoma, these tumors also include giant-cell tumors and osteosarcomas. This chapter will cover the background, epidemiology, genetics, molecular biology, histopathology, radiographic features, clinical manifestations, therapeutic approaches, and clinical management of each entity.

References

Abdallah H, Gersey Z, Muthiah N, McDowell M, Pearce T, Costacou T . An Integrated Management Paradigm for Skull Base Chordoma Based on Clinical and Molecular Characteristics. J Neurol Surg B Skull Base. 2021; 82(6):601-607. PMC: 8563266. DOI: 10.1055/s-0041-1730958. View

Almefty K, Pravdenkova S, Sawyer J, Al-Mefty O . Impact of cytogenetic abnormalities on the management of skull base chordomas. J Neurosurg. 2009; 110(4):715-24. DOI: 10.3171/2008.9.JNS08285. View

Amary F, Berisha F, Ye H, Gupta M, Gutteridge A, Baumhoer D . H3F3A (Histone 3.3) G34W Immunohistochemistry: A Reliable Marker Defining Benign and Malignant Giant Cell Tumor of Bone. Am J Surg Pathol. 2017; 41(8):1059-1068. PMC: 5510691. DOI: 10.1097/PAS.0000000000000859. View

Amit M, Naara S, Binenbaum Y, Billan S, Sviri G, Cohen J . Treatment and Outcome of Patients with Skull Base Chordoma: A Meta-analysis. J Neurol Surg B Skull Base. 2014; 75(6):383-90. PMC: 4240761. DOI: 10.1055/s-0034-1376197. View

Anninga J, Gelderblom H, Fiocco M, Kroep J, Taminiau A, Hogendoorn P . Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand?. Eur J Cancer. 2011; 47(16):2431-45. DOI: 10.1016/j.ejca.2011.05.030. View

Arai M, Nobusawa S, Ikota H, Takemura S, Nakazato Y . Frequent IDH1/2 mutations in intracranial chondrosarcoma: a possible diagnostic clue for its differentiation from chordoma. Brain Tumor Pathol. 2012; 29(4):201-6. DOI: 10.1007/s10014-012-0085-1. View

Bahr A, GAYLER B . Cranial chondrosarcomas. Report of four cases and review of the literature. Radiology. 1977; 124(1):151-6. DOI: 10.1148/124.1.151. View

Bardakhchyan S, Kager L, Danielyan S, Avagyan A, Karamyan N, Vardevanyan H . Denosumab treatment for progressive skull base giant cell tumor of bone in a 14 year old female - a case report and literature review. Ital J Pediatr. 2017; 43(1):32. PMC: 5372271. DOI: 10.1186/s13052-017-0353-0. View

Barzilai O, Fisher C, Bilsky M . State of the Art Treatment of Spinal Metastatic Disease. Neurosurgery. 2018; 82(6):757-769. DOI: 10.1093/neuros/nyx567. View

10.

Behjati S, Tarpey P, Presneau N, Scheipl S, Pillay N, Van Loo P . Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet. 2013; 45(12):1479-82. PMC: 3839851. DOI: 10.1038/ng.2814. View

11.

Biermann J . Common benign lesions of bone in children and adolescents. J Pediatr Orthop. 2002; 22(2):268-73. View

12.

Bloch O, Parsa A . Skull base chondrosarcoma: evidence-based treatment paradigms. Neurosurg Clin N Am. 2012; 24(1):89-96. DOI: 10.1016/j.nec.2012.08.002. View

13.

Bloch O, Jian B, Yang I, Han S, Aranda D, Ahn B . A systematic review of intracranial chondrosarcoma and survival. J Clin Neurosci. 2009; 16(12):1547-51. PMC: 3795514. DOI: 10.1016/j.jocn.2009.05.003. View

14.

Bloch O, Jian B, Yang I, Han S, Aranda D, Ahn B . Cranial chondrosarcoma and recurrence. Skull Base. 2011; 20(3):149-56. PMC: 3037109. DOI: 10.1055/s-0029-1246218. View

15.

Bohman L, Koch M, Bailey R, Alonso-Basanta M, Lee J . Skull base chordoma and chondrosarcoma: influence of clinical and demographic factors on prognosis: a SEER analysis. World Neurosurg. 2014; 82(5):806-14. DOI: 10.1016/j.wneu.2014.07.005. View

16.

Brackmann D, Toh E . Surgical management of petrous apex cholesterol granulomas. Otol Neurotol. 2002; 23(4):529-33. DOI: 10.1097/00129492-200207000-00023. View

17.

Brackmann D, Borne Teufert K . Chondrosarcoma of the skull base: long-term follow-up. Otol Neurotol. 2006; 27(7):981-91. DOI: 10.1097/01.mao.0000233812.48800.b4. View

18.

Campanacci M, Baldini N, Boriani S, Sudanese A . Giant-cell tumor of bone. J Bone Joint Surg Am. 1987; 69(1):106-14. View

19.

Carlson M, OConnell B, Breen J, Wick C, Driscoll C, Haynes D . Petroclival Chondrosarcoma: A Multicenter Review of 55 Cases and New Staging System. Otol Neurotol. 2016; 37(7):940-50. DOI: 10.1097/MAO.0000000000001037. View

20.

Chen X, Bahrami A, Pappo A, Easton J, Dalton J, Hedlund E . Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. Cell Rep. 2014; 7(1):104-12. PMC: 4096827. DOI: 10.1016/j.celrep.2014.03.003. View